Systemic lupus erythematosus (SLE) is an autoimmune disease characterized, in part, by the production of antinuclear antibodies, which appear to play a role in the pathogenesis of the disease. The origin of antinuclear antibodies in SLE is unknown, but there is increasing evidence that their production by B cells is driven by antigen. While there is considerable indirect evidence that T cells are also involved in this process, T cells reacting with nuclear autoantigens have never been demonstrated convincingly. We previously characterized a DNA-binding protein complex termed p7O/p8O (Ku) which is one of the targets of antinuclear antibodies in SLE. Like most lupus autoantigens, Ku is a large macromolecular complex, and antibodies to each component of the complex are generated simultaneously. We hypothesize that the """"""""linked"""""""" production of autoantibodies to p7O, p8O, and DNA might result from T cells reacting with a single component of the Ku complex which provide help for B cells specific for other components (""""""""intermolecular help""""""""). Our recent observation that Ku forms complexes with viral proteins in EpsteinBarr virus and adenovirus infected cells raises the possibility that T cells reacting with viral polypeptides complexed to Ku might provide intermolecular help for Ku autoantibody production. To test the intermolecular help hypothesis, we will first characterize B cell epitopes of Ku using monoclonal antibodies (MAb) to conformational or discontinuous epitopes, and mutant Ku antigens expressed in mammalian cells or bacteria. These studies are a direct extension of our previous work. Second, the viral and cellular proteins complexed to Ku in EBV and adenovirus infected cells will be identified by coimmunoprecipitation from sucrose gradients using Ku MAb, followed by their purification and N-terminal amino acid sequencing. Finally, T-B cell interactions involved in generating antibodies to Ku complexes will be examined in mice. In particular, the role on intermolecular help in producing antibodies to Ku will be tested in murine models to assess whether antiviral T cells might provide help to B cells specific for p7O, p8O, or DNA. Subsequent exploratory studies will be aimed at extending the findings in mice to human autoimmune diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR040391-03
Application #
3160754
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1991-08-01
Project End
1994-01-31
Budget Start
1992-02-01
Budget End
1993-01-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Satoh, M; Vazquez-Del Mercado, M; Krzyszczak, M E et al. (2012) Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma. Lupus 21:68-74
Satoh, Minoru; Chan, Jason Y F; Ross, Steven J et al. (2011) Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins. Arthritis Rheum 63:1972-8
Krzyszczak, Malgorzata E; Li, Yi; Ross, Steven J et al. (2011) Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies. Clin Rheumatol 30:1333-9
Satoh, Minoru; Krzyszczak, Malgorzata E; Li, Yi et al. (2011) Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study. Arthritis Res Ther 13:R73
Ceribelli, Angela; Krzyszczak, Malgorzata E; Li, Yi et al. (2011) Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining. Arthritis Res Ther 13:R119
Kellner, Erinn S; Lee, Pui Y; Li, Yi et al. (2010) Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus. J Neuroimmunol 223:13-9
Kakumanu, Prasanthi; Sobel, Eric S; Narain, Sonali et al. (2009) Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis. J Rheumatol 36:2682-90
Kakumanu, Prasanthi; Yamagata, Hajime; Sobel, Eric S et al. (2008) Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 58:1576-81
Nacionales, Dina C; Kelly-Scumpia, Kindra M; Lee, Pui Y et al. (2007) Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 56:3770-83
Kelly-Scumpia, Kindra M; Nacionales, Dina C; Scumpia, Philip O et al. (2007) In vivo adjuvant activity of the RNA component of the Sm/RNP lupus autoantigen. Arthritis Rheum 56:3379-86

Showing the most recent 10 out of 74 publications